CE, FDA and Free Sale Evidence for Medical Devices in Morocco

1. Key takeaways

Morocco accepts CE marking and United States Food and Drug Administration (FDA) certification as market access evidence for imported devices, but the acceptance is tiered by class. For Class IIA and above, and for the Is and Im subcategories of Class I, the dossier must include a CE marking certificate, FDA certification, or a marketing authorization or free sale certificate issued by the competent authority of the country of origin. For Class III, a CE design examination certificate is additionally required. GRZAN positions these documents as materials that support registration but cannot replace it: they answer an evidence question, not a licensing question.

The distinction matters because the most common misconception in the Moroccan market is that holding a CE certificate is itself permission to sell. It is not. The registration obligation under Article 12 exists independently of any foreign certification, and a CE certificate is only one item of evidence inside the dossier required by Article 14. Selling in Morocco on the strength of a CE certificate without completing registration still falls within the turnover-based penalties of Article 44.

For manufacturers without CE or FDA documentation there is still a route. A marketing authorization or free sale certificate from the competent authority of the country of origin satisfies the formal requirement, and for Chinese manufacturers the workable combination is an NMPA registration certificate together with a free sale certificate. What decides success in that route is the verifiability of the documents and the quality of their French translation.

2. Legal basis

Practical estimate: the specific wording of the tiering rules comes from public information in Arrêté n° 2855-15 and the current AMMPS checklist, organized by GRZAN according to the checklist in force. The requirement that Class III devices need a CE design examination certificate is a practical estimate and should be re-verified before submission.

3. Expert insights

Insight one: the three evidence types are alternatives, but they are not equal in weight. The provisions and the checklist accept a CE certificate or FDA certification or a marketing authorization or free sale certificate from the competent authority of the country of origin. Any one of the three satisfies the formal requirement, yet their persuasive force in review differs. A CE certificate, especially one carrying a notified body number, and an FDA clearance or approval usually carry more weight than a generic free sale certificate, because they contain a conformity assessment conclusion rather than a bare statement that the product is marketed at home.

Insight two: the Is and Im subcategories are the most commonly missed tier. Sterile devices (Is) and devices with a measuring function (Im) are pulled up to the same evidence tier as Class IIA. A dossier prepared on the assumption of an ordinary Class I product will be met with a request for supplementary documents in the first round if the product is in fact sterile or has a measuring function. Checking the actual subcategory at project start costs nothing and prevents a full lost cycle.

Insight three: a CE certificate cannot substitute for the registration certificate. This remains the most frequent misunderstanding in the Moroccan market. The registration obligation of Article 12 stands independently, and the CE certificate is merely one item of evidence within the dossier of Article 14. Selling with a CE certificate in hand but without registration still falls within the scope of the turnover-based penalties of Article 44. Distributors and licensed establishments should treat this point as a standing rule in commercial negotiations.

Insight four: validity periods and internal consistency are the hidden killers of evidence packages. If the CE certificate is close to expiry, the ISO 13485 certificate has lapsed, or the free sale certificate is dated long before submission, the whole set of documents can be called into question. Inconsistencies in the manufacturer name, address, or product model across certificates are equally damaging. GRZAN recommends adding a certificate consistency cross-reference table to the dossier, so that every name, address, and model string is checked once against all other documents before filing.

Insight five: products without CE or FDA documentation still have a path. A marketing authorization or free sale certificate issued by the competent authority of the country of origin satisfies the formal requirement. For Chinese manufacturers, the workable combination is an NMPA registration certificate plus a free sale certificate. The decisive factors are the verifiability of the issuing source and the quality of the French translation: model numbers and technical terms in the translation must match the rest of the dossier exactly, or the reviewer will treat the mismatch as a substantive doubt.

4. Practical recommendations

1. Select evidence by class, neither more nor less. Use the tiering table to fix the required documents, prepare Is and Im devices to the Class IIA level, and add the design examination certificate for Class III.
2. Prefer certificates containing a conformity assessment conclusion. Where a CE certificate exists, use it; where none exists, prepare the combination of an NMPA registration certificate and a free sale certificate, and confirm the issuing authority details before filing.
3. Build a certificate consistency cross-reference table. Check the manufacturer name, address, product model, and validity period across every certificate in the dossier, field by field, before submission.
4. Handle French translation early. All foreign-language certificates must carry a French translation, and the model numbers and terminology used in the translations must be unified with the rest of the dossier.
5. Start certificate renewals before expiry. Track validity periods in the version register and trigger renewal when a certificate is within 3 months of expiry, so that no document lapses between submission and decision.

5. Verification checklist

• □ Required evidence documents confirmed for the device class
• □ Is and Im subcategories prepared to the Class IIA evidence tier
• □ CE design examination certificate prepared for Class III (practical estimate)
• □ At least one of the CE certificate, FDA certification, or free sale certificate obtained and valid
• □ Manufacturer name, address, and model information consistent across all certificates
• □ French translations attached to foreign-language certificates with unified terminology
• □ Certificate validity register established with a 3-month early warning

GRZAN assists manufacturers in assembling market access evidence for medical device registration in Morocco, including the selection of CE, FDA, and free sale documentation according to device class, certificate consistency reviews, French translation coordination, and validity tracking. For support with registration documentation and conformity files for the Moroccan market, contact GRZAN at info@grzanglobal.com.

Regulatory information verified as of 30 October 2026